Publication:
Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake

dc.contributor.authorMartin-Gutierrez, G.
dc.contributor.authorDocobo-Perez, F.
dc.contributor.authorRodriguez-Beltran, J.
dc.contributor.authorRodriguez-Martinez, J. M.
dc.contributor.authorAznar, J.
dc.contributor.authorPascual, A.
dc.contributor.authorBlazquez, J.
dc.contributor.authoraffiliation[Martin-Gutierrez, G.] Hosp Univ Virgen del Rocio, Unidad Enfermedades Infecciosas Microbiol & Med P, Seville, Spain
dc.contributor.authoraffiliation[Aznar, J.] Hosp Univ Virgen del Rocio, Unidad Enfermedades Infecciosas Microbiol & Med P, Seville, Spain
dc.contributor.authoraffiliation[Blazquez, J.] Hosp Univ Virgen del Rocio, Unidad Enfermedades Infecciosas Microbiol & Med P, Seville, Spain
dc.contributor.authoraffiliation[Martin-Gutierrez, G.] Inst Biomed Sevilla IBiS, Seville, Spain
dc.contributor.authoraffiliation[Docobo-Perez, F.] Inst Biomed Sevilla IBiS, Seville, Spain
dc.contributor.authoraffiliation[Rodriguez-Beltran, J.] Inst Biomed Sevilla IBiS, Seville, Spain
dc.contributor.authoraffiliation[Rodriguez-Martinez, J. M.] Inst Biomed Sevilla IBiS, Seville, Spain
dc.contributor.authoraffiliation[Aznar, J.] Inst Biomed Sevilla IBiS, Seville, Spain
dc.contributor.authoraffiliation[Pascual, A.] Inst Biomed Sevilla IBiS, Seville, Spain
dc.contributor.authoraffiliation[Pascual, A.] Hosp Univ Virgen Macarena, Unidad Enfermedades Infecciosas & Microbiol, Seville, Spain
dc.contributor.authoraffiliation[Docobo-Perez, F.] Inst Salud Carlos III, REIPI, Madrid, Spain
dc.contributor.authoraffiliation[Rodriguez-Martinez, J. M.] Inst Salud Carlos III, REIPI, Madrid, Spain
dc.contributor.authoraffiliation[Pascual, A.] Inst Salud Carlos III, REIPI, Madrid, Spain
dc.contributor.authoraffiliation[Blazquez, J.] Inst Salud Carlos III, REIPI, Madrid, Spain
dc.contributor.authoraffiliation[Docobo-Perez, F.] Univ Seville, Dept Microbiol, Seville, Spain
dc.contributor.authoraffiliation[Rodriguez-Martinez, J. M.] Univ Seville, Dept Microbiol, Seville, Spain
dc.contributor.authoraffiliation[Aznar, J.] Univ Seville, Dept Microbiol, Seville, Spain
dc.contributor.authoraffiliation[Pascual, A.] Univ Seville, Dept Microbiol, Seville, Spain
dc.contributor.authoraffiliation[Blazquez, J.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain
dc.contributor.authoraffiliation[Rodriguez-Martinez, J. M.] Hosp Univ Ramon y Cajal IRYCIS, Dept Microbiol, Madrid, Spain
dc.contributor.funderPlan Nacional de I + D + i
dc.contributor.funderInstituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases
dc.contributor.funderEuropean Development Regional Fund "A Way to Achieve Europe"-by Operative Program Intelligent Growth from Instituto de Salud Carlos III
dc.contributor.funderConsejeria de Salud, Junta de Andalucia
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderVPPI-US fellowship from the University of Sevilla
dc.date.accessioned2023-02-12T02:21:38Z
dc.date.available2023-02-12T02:21:38Z
dc.date.issued2018-01-01
dc.description.abstractThe steps by which Escherichia coli strains harboring mutations related to fosfomycin (FOS) resistance arise and spread during urinary tract infections (UTIs) are far from being understood. The aim of this study was to evaluate the effects of urine, pH, and anaerobiosis on FOS activity against a set of isogenic strains carrying the most prevalent chromosomal mutations conferring FOS resistance (Delta uhpT,Delta glpT,Delta cyaA, and Delta ptsI), either singly or in combination. We also studied fosfomycin-resistant E. coli clinical isolates from patients with UTI. Our results demonstrate that urinary tract physiological conditions might have a profound impact on FOS activity against strains with chromosomal FOS resistance mutations. Specifically, acidic pH values and anaerobiosis convert most of the strains categorized as resistant to fosfomycin according to the international guidelines to a susceptible status. Therefore, urinary pH values may have practical interest in the management of UTIs. Finally, our results, together with the high fitness cost associated with FOS resistance mutations, might explain the low prevalence of fosfomycin-resistant E. coli variants in UTIs.
dc.identifier.doi10.1128/AAC.01899-17
dc.identifier.essn1098-6596
dc.identifier.issn0066-4804
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc5740309?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/19005
dc.identifier.wosID418565300049
dc.issue.number1
dc.journal.titleAntimicrobial agents and chemotherapy
dc.journal.titleabbreviationAntimicrob. agents chemother.
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.publisherAmer soc microbiology
dc.rights.accessRightsopen access
dc.subjectfosfomycin activity
dc.subjectfosfomycin resistance
dc.subjectchromosomal mutations
dc.subjectUTI
dc.subjectEscherichia coli
dc.subjecturinary tract infection
dc.subjectResistant klebsiella-pneumoniae
dc.subjectDose oral treatment
dc.subjectIntravenous fosfomycin
dc.subjectBacterial-growth
dc.subjectInfections
dc.subjectImpact
dc.subjectTissue
dc.subjectPhosphonomycin
dc.subjectSusceptibility
dc.subjectEpidemiology
dc.titleUrinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number62
dc.wostypeArticle
dspace.entity.typePublication

Files